EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications

Wei Du, Shunsuke Koga iD, Guang Yang, Saar Gill, Adam Bagg

International Journal of Laboratory Hematology · 2026

DOI: 10.1111/ijlh.70181 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, 2026. Verfasst von Wei Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Immunotherapy, Adoptive, Hematologic Neoplasms, Receptors, Chimeric Antigen. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clonal hematopoiesis (CH) is increasingly recognized as a significant biological phenomenon in aging and cancer, marked by the expansion of hematopoietic stem and progenitor cells harboring somatic mutations in genes associated with myeloid neoplasms. While CH is strongly linked to a spectrum of inflammatory diseases and hematologic malignancies, its role in shaping responses to cancer immunotherapy—especially chimeric antigen receptor (CAR) T cell therapy—has only recently begun to emerge. This review explores the interplay between CH and CAR T cell therapy, highlighting CH prevalence in treated populations, post‐therapy clonal dynamics, inflammatory toxicities, and risk of therapy‐related myeloid neoplasms. We also discuss the differential effects of specific CH mutations on hematopoiesis, immune cell function, and CAR T cell persistence. Understanding the functional implications of CH in the context of CAR T cell therapy holds the potential to refine patient selection, tailor toxicity management, and develop personalized immunotherapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisImmunotherapy, AdoptiveHematologic NeoplasmsReceptors, Chimeric AntigenHumansT-LymphocytesAnimalsMutation

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Shunsuke Koga

Zitieren

APA

Du, W., Koga, S., Yang, G., Gill, S., & Bagg, A. (2026). Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.70181

Vancouver

Du W, Koga S, Yang G, Gill S, Bagg A. Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications. International Journal of Laboratory Hematology. 2026. doi:10.1111/ijlh.70181

BibTeX
@article{Du2026,
  author = {Du, Wei and Koga, Shunsuke and Yang, Guang and Gill, Saar and Bagg, Adam},
  title = {Clonal Hematopoiesis and CAR T Cell Therapy: From Biological Crosstalk to Clinical Implications},
  journal = {International Journal of Laboratory Hematology},
  year = {2026},
  doi = {10.1111/ijlh.70181}
}
Kostenlos starten →